Skip to main content
OpenTrials

Clinical trial condition

Infections, Papillomavirus

Explore clinical trials studying Infections, Papillomavirus. Study availability and eligibility vary by location and protocol.

61 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Infections, Papillomavirus trial results

Completed

Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18

NCT00122681

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Fountain Valley, California, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site San Francisco, California, United States
View all 138 locations
View Trial Details
Completed

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects

NCT00578227

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Surrey, British Columbia, Canada
  • GSK Investigational Site Brampton, Ontario, Canada
  • GSK Investigational Site Greater Sudbury, Ontario, Canada
  • GSK Investigational Site Newmarket, Ontario, Canada
View all 21 locations
View Trial Details
Completed

Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects

NCT00652938

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Nijmegen, Netherlands
  • GSK Investigational Site Rotterdam, Netherlands
  • GSK Investigational Site Linköping, Sweden
  • GSK Investigational Site Luleå, Sweden
View Trial Details
Completed

Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs

NCT00541970

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Edmonton, Alberta, Canada
  • GSK Investigational Site Langley, British Columbia, Canada
  • GSK Investigational Site St. John's, Newfoundland and Labrador, Canada
  • GSK Investigational Site Truro, Nova Scotia, Canada
View all 25 locations
View Trial Details

Related conditions